GGrantIndex
Sort

30,917 grants matching tumor microenvironment

Nanoparticle Transport Through Tissues

$300,000
Erkki I Ruoslahti · Sanford Burnham Prebys Medical Discovery Institute · R56 · FY2017 · CA

Emory-GA Tech Nanotechnology Center for Personalized an*

$300,000
Shuming Nie · Emory University · U54 · FY2009 · CA

Angiogenesis antagonist plus CD40-TLR agonist adjuvant combination vaccine

$300,000
Susan Dana Jones · Immurx Llc · R43 · FY2010 · AI

Non-Activated Natural Killer Cell Engineering For Enhanced Cytotoxic Potential

$300,000
Bethany Foch Grant · Kytopen Corp · R44 · FY2021 · AI

VISTA: A Novel Therapeutic Target That Negatively Regulates Immunity

$300,000
Susan Dana Jones · Immurx Llc · R43 · FY2011 · AI

Cancer Center Support Grant 2018-2023

$300,000
Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2020 · CA

Polyionic Papillomavirus-like Particles (VLP) for the Treatment of HPV+ oropharyngeal squamous cell carcinomas (OPCs)

$300,000
Joshua Weiyuan Wang · Pathovax, Llc · R41 · FY2017 · CA

BRING-SynBio: Deciphering and directing lactylation epigenetics to control macrophage immune cell phenotype

$300,000
Catherine Fromen · University Of Delaware · · FY2025 · ENG

TUMOR MICROENVIRONMENT GENE SIGNATURE AS A PROGNOSTIC CLASSIFIER AND THERAPEUTIC TARGET

$300,000
Cedars-Sinai Medical Center · · FY2014 · Department of Defense

Patient Derived Xenograft (PDX) Model in Humanized NOG Mice: Evaluation and Validation of Immuno-oncology Agents

$300,000
Gerold Feuer · Humurine Technologies, Inc. · R43 · FY2016 · CA

Molecular MR Imaging of the Desmoplastic Response in Pancreatic Cancer

$300,000
Valerie Humblet · Collagen Medical, Llc · R44 · FY2015 · CA

ORION: Oncology Research Integration using OHDSI-based NLP (NCI Cancer Informatics Scholar)

$300,000
Anil K Rustgi · Columbia University Health Sciences · P30 · FY2023 · CA

Caveolae-Targeted Cisplatin Immunoconjugates for Effective Lung Cancer Therapy

$299,999
Michael David Levin · Cavatar, Llc · R41 · FY2017 · CA

Differences in Tumor Biology of Multiple Myeloma in Association with African Ancestry

$299,999
Linda B Baughn · Mayo Clinic Rochester · R56 · FY2022 · CA

Topic 396 - Imaging for Cancer Immunotherapies-Moonshot

$299,999
Arfaan Rampersaud · Columbus Nanoworks, Inc. · N43 · FY2019 · CA

Elucidating novel epigenetic modifications implicated in multiple myeloma risk disparities

$299,993
Brian C-H Chiu · University Of Chicago · R56 · FY2023 · CA

Biomimetic nanovesicles to overcome multiple physiological barriers for primary and metastatic triple negative breast cancer therapy

$299,992
Jenny C-N Chang · Methodist Hospital Research Institute · R56 · FY2017 · CA

FIBROUS SCAFFOLD-INDUCED SPHEROIDS MIMICKING TME

$299,992
Sandhya Boyapalle · Transgenex Nanobiotech, Inc. · N43 · FY2013 · CA

IGF::OT::IGF SUPPORT- ADMINISTRATIVE: OTHER

$299,986
Thomas Neumann · Nortis, Inc. · N43 · FY2013 · CA

Therapeutic peptide for hepatocellular carcinoma

$299,983
Niranjan B Pandey · Asclepix Therapeutics, Inc. · R43 · FY2018 · CA

Targeting Hepatocyte Growth Factor Processing and Activation in Lung Cancer

$299,980
Lidija Klampfer · Protexase Therapeutics, Inc. · R43 · FY2018 · CA

Development of a vault nanovaccine for pancreatic cancer immunotherapy

$299,979
Gayle Boxx · Aukera, Inc. · R43 · FY2019 · CA

Design of a micro-RNA attenuated armed oHSV for the treatment of glioblastoma

$299,976
Christophe Queva · Oncorus, Inc. · R43 · FY2019 · CA

Role of Stat3 in tumor immune evasion and immune suppression

$299,975
Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2006 · CA

Role of Stat3 in modulating tumor microenvironnment and angiogenesis

$299,975
Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2006 · CA